Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $147.60 +2.90%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- BILL posts stronger Q4 revenue, profit growth but sees slower fiscal 2027
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
